Concepedia

Sarah Hamidi

SH

5

Publications

141

Citations

5

H-Index

2020

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Sarah Hamidi is an author at The University of Texas MD Anderson Cancer Center.

ORCID

Publications per year

2020–2024

5

Publications

5

Checkpoint Inhibition in Addition to Dabrafenib/Trametinib for BRAF <sup>V600E</sup> -Mutated Anaplastic Thyroid Carcinoma

Sarah Hamidi, Priyanka Iyer, Ramona Dadu et al. · Thyroid · 2024 · 61 citations

Initial Management of <i>BRAF </i>V600E-Variant Anaplastic Thyroid Cancer

Sarah Hamidi, Ramona Dadu, Mark Zafereo et al. · JAMA Oncology · 2024 · 28 citations

Lenvatinib Therapy for Advanced Thyroid Cancer: Real-Life Data on Safety, Efficacy, and Some Rare Side Effects

Sarah Hamidi, Andrée Boucher, Bernard Lemieux et al. · Journal of the Endocrine Society · 2022 · 21 citations · Full text

Brown tumor of the iliac crest initially misdiagnosed as a giant cell tumor of the bone

Sarah Hamidi, Sophie Mottard, Marie-Josée Berthiaume et al. · Endocrinology Diabetes and Metabolism Case Reports · 2020 · 19 citations · Full text

RET kinase inhibitors for the treatment of RET-altered thyroid cancers: Current knowledge and future directions

Sarah Hamidi, Mimi I. Hu · Annales d Endocrinologie · 2024 · 12 citations

Rows per page

1–5 of 5